Tag: FDA

Steps for Investigating Tablet Lamination during High-Speed Manufacturing Runs Tablet lamination—a defect characterized by the formation of a layer or film on the surface of tablets—can significantly impact product efficacy…

Addressing Lamination Issues in Tablet Tech Transfer: A Comprehensive Investigation Approach Lamination of tablets during tech transfer is a significant issue that can result in out-of-specification (OOS) findings, impacting quality…

GMP Investigation Procedures for Blend Segregation during High-Speed Runs In the context of pharmaceutical manufacturing, blend segregation is a critical issue, especially during high-speed runs of solid oral dosage forms…

Addressing Sticking and Picking Issues for FDA Inspection Readiness: Essential Investigation Steps and Batch Disposition In pharmaceutical manufacturing, sticking and picking during the processing of solid oral dosage forms pose…

Investigation Steps for Out-of-Test Dissolution Trends in Multi-Strength Campaigns In pharmaceutical manufacturing, particularly in solid oral dosage forms like tablets and capsules, maintaining product quality is an essential priority. A…

Investigating Capsule Shell Brittleness during Compression: Key GMP Steps The issues surrounding capsule shell brittleness during compression can significantly impact batch quality and production efficiency in pharmaceutical manufacturing. As professionals…

Addressing the Issues of Sticking and Picking Following an Excipient Change Sticking and picking of tablets during manufacturing processes can significantly impact product quality and batch release. These defects often…